Fecal Putative Uropathogen Abundance and Antibiotic Resistance Gene Carriage in Women With Refractory Recurrent Urinary Tract Infection Treated With Fecal Microbiota Transplantation

被引:3
|
作者
Jeney, Sarah E. S. [1 ]
Avelar-Barragan, Julio [2 ]
Whiteson, Katrine [2 ]
Chang, Jenny [2 ]
Dutta, Sonia [3 ]
Lane, Felicia [1 ]
机构
[1] Univ Calif Irvine, Obstet & Gynecol, Irvine, CA 92717 USA
[2] Univ Calif Irvine, Sch Biol Sci, Irvine, CA 92717 USA
[3] NorthShore Univ Hlth Syst, Obstet & Gynecol, Skokie, IL USA
来源
FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY | 2022年 / 28卷 / 04期
关键词
antibiotic resistance; fecal microbiome; microbiome; recurrent urinary tract infection; urinary tract infection; BETA-LACTAMASE; MACROLIDE; ALIGNMENT;
D O I
10.1097/SPV.0000000000001090
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective The aims of this study were to describe the fecal relative abundance of potentially uropathogenic bacteria and to analyze antibiotic resistance genes before and after fecal microbiota transplantation in women with recurrent urinary tract infection (UTI). Methods Shotgun sequencing was performed on fecal samples from 3 donors and 4 women with recurrent UTI who underwent transplantation. Recipient samples were sequenced at baseline and at 4 time points through 6 months postintervention. Relative fecal uropathogen abundance was analyzed by species and participant using descriptive statistics. Antibiotic resistance gene abundance was assigned, normalized, and compared between donors and recipients at baseline and postintervention using an abundance bar plot, nonmetric multidimensional scaling, and pairwise permutational multivariate analysis of variance. Results The median (range) relative abundance of Escherichia coli in all fecal samples from women with recurrent UTI was 0% (0%-5.10%); Enterococcus faecalis, 0% (0%-0.20%); Enterococcus faecium, 0% (0%-1.90%); Klebsiella pneumoniae, 0% (0%-0.10%); and Pseudomonas aeruginosa, 0% (0%-0.10%). Gut microbes carried genes conferring resistance to antibiotics used for UTI. No significant difference was seen in antibiotic resistance gene carriage after transplantation compared with baseline (P=0.22, R-2=0.08 at 3 months). Antibiotic gene composition and abundance were significantly associated with the individual from whom the sample came (P=0.004, R-2=0.78 at 3 months). Conclusions Exploratory analysis of gut microbiomes in women with recurrent UTI identifies no or low relative putative uropathogen abundance for all species examined. Antibiotic resistance gene carriage persisted after fecal microbiota transplantation, although conclusions are limited by small sample size.
引用
收藏
页码:213 / 219
页数:7
相关论文
共 9 条
  • [1] Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection
    Biehl, Lena M.
    Aguilar, Rebeca Cruz
    Farowski, Fedja
    Hahn, Werner
    Nowag, Angela
    Wisplinghoff, Hilmar
    Vehreschild, Maria J. G. T.
    INFECTION, 2018, 46 (06) : 871 - 874
  • [2] Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection
    Lena M. Biehl
    Rebeca Cruz Aguilar
    Fedja Farowski
    Werner Hahn
    Angela Nowag
    Hilmar Wisplinghoff
    Maria J. G. T. Vehreschild
    Infection, 2018, 46 : 871 - 874
  • [3] Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency
    Tariq, Raseen
    Pardi, Darrell S.
    Tosh, Pritish K.
    Walker, Randall C.
    Razonable, Raymund R.
    Khanna, Sahil
    CLINICAL INFECTIOUS DISEASES, 2017, 65 (10) : 1745 - 1747
  • [4] Fecal Microbiota Transfer for Clostridium difficile Infection and Its Effects on Recurrent Urinary Tract Infection
    Wood, Nicole
    Propst, Katie
    Yao, Meng
    Ferrando, Cecile A.
    UROGYNECOLOGY, 2023, 29 (10): : 814 - 826
  • [5] Fecal Microbiota Transplant for Refractory Clostridium difficile Infection Interrupts 25-Year History of Recurrent Urinary Tract Infections
    Wang, Tiffany
    Kraft, Colleen S.
    Woodworth, Michael H.
    Dhere, Tanvi
    Eaton, Molly E.
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (02):
  • [6] Successful Fecal Microbiota Transplantation in a Patient Suffering From Irritable Bowel Syndrome and Recurrent Urinary Tract Infections
    Hocquart, Marie
    Pham, Thao
    Kuete, Edmond
    Tomei, Enora
    Lagier, Jean Christophe
    Raoult, Didier
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (10):
  • [7] Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening?
    Vendrik, Karuna E. W.
    de Meij, Tim G. J.
    Bokenkamp, Arend
    Ooijevaar, Rogier E.
    Groenewegen, Bas
    Hendrickx, Antoni P. A.
    Terveer, Elisabeth M.
    Kuijper, Ed J.
    van Prehn, Joffrey
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (07):
  • [8] A Case of Successful Treatment of Recurrent Urinary Tract Infection by Extended-Spectrum β-Lactamase Producing Klebsiella pneumoniae Using Oral Lyophilized Fecal Microbiota Transplant
    Bier, Naomi
    Hanson, Blake
    Jiang, Zhi-Dong
    DuPont, Herbert L.
    Arias, Cesar A.
    Miller, William R.
    MICROBIAL DRUG RESISTANCE, 2023, 29 (01) : 34 - 38
  • [9] Fecal microbiota transplantation for patients on antibiotic treatment with C. difficile infection history (GRAFT): Study protocol for a phase II, randomized, double-blind, placebo-controlled trial to prevent recurrent C. difficile infections
    Kates, Ashley E.
    Gaulke, Ilsa
    De Wolfe, Travis
    Zimbric, Michele
    Haight, Kendra
    Watson, Lauren
    Suen, Garret
    Kim, Kyungmann
    Safdar, Nasia
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2020, 18